Amy Siegel

Posts by

MedCity Influencers

The Rise of Robotics in Med Tech

Robots represent a vision of the future, a vision that inspires two parts amazement and one part fear of being replaced by superior machines. In manufacturing, robots have been deployed since the 1960’s to exceed human precision and productivity. This same potential exists in the provision of healthcare, but to date robots have barely made a dent.

MedCity Influencers

Europe Ups the Post-Market Ante for New Medical Devices

While Europe may still provide a faster route to regulatory approval for such devices, post-market requirements are creeping in like an expensive final cheese course served by European regulators and health systems just when companies are feeling most broke and tired. So regulatory approvals may come, but actual, meaningful revenues? Not so fast.

MedCity Influencers

The Next Big Niche? Emerging Med-Tech for Transplant.

As an advisor to emerging med tech companies, I am always on the lookout for attractive niche markets where new technologies might get a foothold and demonstrate their value before taking on the (often mythical) billion-dollar opportunity. To this end, for years I have instinctively gravitated toward the transplant market (the solid organ kind, e.g. kidneys, livers, hearts, pancreases, etc…) as a nifty space for novel medical devices and diagnostics.

MedCity Influencers

When Medical Devices Go Quiet: Managing End of Life

The past few weeks have culminated in a sorrowful irony for me, as my father advanced to the final, terminal stages of heart failure. Professionally I am immersed in a universe of promising new medical devices, while personally I witnessed the one-by-one elimination of technological solutions for my father’s grave condition.

Devices & Diagnostics

Top 5 anxiety-provoking medtech acronyms

cronyms are popular because they serve the useful purpose of expediting communication, creating a tribal sense of community for those in the know, and conveying the (sometimes false) perception of vast expertise to the uninitiated. There are certain acronyms, however, that strike fear into the heart of the med-tech entrepreneur. Upon mention of these TLAs, the tension in the room is palpable as brains silently begin to revise development timelines, budgets and cash out dates.

Devices & Diagnostics

Aligning Stakeholders in Emerging Med Tech Companies

In a functioning emerging med tech family, there is a healthy level of tension among the various stakeholders, each with a unique perspective on how best to grow the value of the company (and thus their stake in it). Sometimes, though, the incentives and motivations are in such opposition that value or even whole companies can be destroyed, or worse just limp along zombie-like in defiance of all logic.

Devices & Diagnostics

How low can you go? Creating value with cheap medical devices

...we ask ourselves whether the small emerging med-tech company can achieve success (and funding) with a “tons cheaper” value proposition. In theory, any company starting fresh with design and manufacturing should be able to take advantage of Moore’s law in a way that the big guys with vast installed bases and capital investments can’t. The opportunity for success is there, but not every company or technology is cut out to win at price-cutting.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

Devices & Diagnostics

The 10 Cs you need to lead an emerging medtech company

There have been many books, articles and probably blogs written about what it takes to corner the corner office. When that corner office is overlooking the HVAC system of a sub-sub-leased space crammed with tired-looking engineers, low-paid summer interns, 3 day old pizza, EBAY-purchased testing devices, duct tape covered chairs, and the strewn parts of multiple cannibalized pieces of equipment, otherwise known as a start-up med tech company, different rules apply.

Devices & Diagnostics

Back to Basics: The Surgical Segment Heats Up

With all the turmoil in the US healthcare market, a port in the storm is not easy to find. A port that can accommodate an outsized tanker ship like Medtronic is even harder to locate. With two back-to-back acquisitions last month of Peak Surgical and Salient Surgical, the S.S. Medtronic took refuge in Surgery Harbor, committing nearly $600 million (net of previous ownership stakes) in a single day to nestle in with the hulking barges of Covidien and J&J.

Devices & Diagnostics

First Stop, Third World: Emerging Markets For Med Tech

...maybe it is time to lift our transatlantic heads up and take in the view of the rest of the planet. While we run back and forth to Europe, clogging our arteries with triple-cream brie, a whole developing world chock full o’ unmet medical needs and experiencing enviable GDP growth goes largely untapped by emerging med tech companies.